Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cardio Diagnostics Holdings (CDIO) Equity Average (2021 - 2025)

Cardio Diagnostics Holdings' Equity Average history spans 5 years, with the latest figure at $8.9 million for Q3 2025.

  • For Q3 2025, Equity Average rose 164.43% year-over-year to $8.9 million; the TTM value through Sep 2025 reached $8.9 million, up 164.43%, while the annual FY2024 figure was $6.3 million, 72.4% up from the prior year.
  • Equity Average for Q3 2025 was $8.9 million at Cardio Diagnostics Holdings, down from $10.6 million in the prior quarter.
  • Across five years, Equity Average topped out at $10.6 million in Q2 2025 and bottomed at $24441.0 in Q3 2021.
  • The 5-year median for Equity Average is $3.4 million (2024), against an average of $4.8 million.
  • The largest annual shift saw Equity Average skyrocketed 39332.5% in 2022 before it tumbled 73.04% in 2023.
  • A 5-year view of Equity Average shows it stood at $546194.0 in 2021, then skyrocketed by 1170.09% to $6.9 million in 2022, then plummeted by 62.19% to $2.6 million in 2023, then soared by 152.47% to $6.6 million in 2024, then soared by 34.98% to $8.9 million in 2025.
  • Per Business Quant, the three most recent readings for CDIO's Equity Average are $8.9 million (Q3 2025), $10.6 million (Q2 2025), and $10.5 million (Q1 2025).